We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
ParAllele BioScience has announced the issuance by the U.S. Patent Office of
a key patent (6,858,412) covering its Molecular Inversion Probe (MIP) technology.
Merlyn Associates has announced the introduction of four additional products
to their innovative EndoFlex line, which features endotracheal tubes with a
patented adjustable distal tip.
SurModics, a provider of surface modification and drug delivery technologies
to the healthcare industry, announced that its board of directors has elected
Bruce Barclay to the position of president and CEO, effective July 1.
Micro Dynamics (MDC), a provider of electronic contract manufacturing services
(EMS), announced its Eden Prairie, Minn., facility has achieved ISO 13485:2003
certification.
Andromed has initiated its clinical validation study on Androflo, a noninvasive
diagnostic tool allowing the continuous real-time measurement of respiratory
rate.
Ev3, a privately held endovascular medical device company, has received approval
to include the SpideRX Embolic Protection Device in the second arm of the company's
carotid clinical trial.
Stratagene, a developer, manufacturer and marketer of specialized life science
research and diagnostic products, announced that its wholly owned subsidiary,
Hycor Biomedical, has received clearance from the FDA to market its Anti-Tissue
Transglutaminase (tTG) IgG (Immunoglobulin G) autoimmune test in the U.S.